Journal of Cancer Prevention : pISSN 2288-3649 / eISSN 2288-3657

Fig. 1.

Download original image
Fig. 1. Cell proliferative activity of gefitinib in non-small-cell lung cancer cell lines. The cells were treated with gefitinib for 48 hours (A) or 48 and 72 hours (B). The cell proliferation was then determined by the sulforhodamine B assay as described in Materials and Methods.
Journal of Cancer Prevention 2019;24:217-23 https://doi.org/10.15430/JCP.2019.24.4.217
© 2019 Journal of Cancer Prevention